Physician

Yong Tang, M.D.

According to 2025 Medicare claims, Yong Tang, M.D. (NPI: 1093913527) practices hematology/oncology in the Hagerstown-Martinsburg, MD-WV market, with the plurality of this provider's patient population coming from Washington, MD. This provider's primary affiliated billing organization is ANTIETAM ONCOLOGY & HEMATOLOGY GROUP, PC (NPI: 1205878980; TIN: 204253140) and primary practice location at 21740-6670. Tang is affiliated with the ACO West Virginia (ACO ID: A3563) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Tang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 685 traditional Medicare patients, billed 330,728 HCPCS/CPT codes, and received $4,774,534 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,702 prescription claims across 261 beneficiaries totaling $4,726,089 in drug costs, led by Revlimid (Lenalidomide). DME data shows 214 claims. Open Payments data shows 156 records totaling $3,757. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $827,834 to $4,774,534. Similarly, Part D prescription costs have moved sharply higher in recent years, from $652,022 to $4,726,089. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	450	87,230	$827,834
2016	527	97,258	$816,337
2017	547	88,866	$940,844
2018	525	118,236	$1,632,957
2019	592	158,681	$1,915,485
2020	661	182,871	$2,562,408
2021	726	202,586	$3,325,356
2022	802	259,959	$4,552,294
2023	713	257,818	$4,531,360
2024	685	330,728	$4,774,534

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	119	1,153	$652,022
2016	127	1,099	$1,245,507
2017	153	1,095	$1,785,451
2018	136	1,195	$1,750,128
2019	161	1,234	$2,358,576
2020	166	1,326	$2,913,405
2021	207	1,354	$3,318,033
2022	262	1,744	$5,094,090
2023	256	1,792	$4,574,290
2024	261	1,702	$4,726,089

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	45	$3,423
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	54	$2,841
2023	N/R	43	$12,018
2024	N/R	214	$97,799

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	88	105	$138
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	218	515	$102
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	77	77	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	542	1,054	$69
96375	Injection of additional new drug or substance into vein	76	1,196	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	46	1,288	$810,928
Imbruvica	Ibrutinib	46	1,380	$524,724
Reblozyl	Luspatercept-Aamt	37	705	$513,140
Erleada	Apalutamide	26	780	$382,885
Tasigna	Nilotinib Hcl	13	364	$256,367

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4197	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix	N	N/R	39	$74,861
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	38	$11,675
B4224	Parenteral nutrition administration kit, per day	N	N/R	39	$6,692
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	39	$2,143
J8521	Capecitabine, oral, 500 mg	N	N/R	24	$1,203

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	156	$3,757	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yong Tang, M.D.?

Tedicare shows public-source Medicare data for Yong Tang, M.D. (NPI 1093913527), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yong Tang, M.D. have ACO affiliation data?

Yong Tang, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Yong Tang, M.D.?

Yong Tang, M.D. is linked to ANTIETAM ONCOLOGY & HEMATOLOGY GROUP, PC (billing NPI 1205878980) in the available physician profile data.

Does Yong Tang, M.D. have Open Payments data?

Yong Tang, M.D. has 156 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.